<SEC-DOCUMENT>0001193125-25-224160.txt : 20250930
<SEC-HEADER>0001193125-25-224160.hdr.sgml : 20250930
<ACCEPTANCE-DATETIME>20250930084823
ACCESSION NUMBER:		0001193125-25-224160
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20250930
DATE AS OF CHANGE:		20250930

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			STAAR SURGICAL CO
		CENTRAL INDEX KEY:			0000718937
		STANDARD INDUSTRIAL CLASSIFICATION:	OPHTHALMIC GOODS [3851]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				953797439
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1227

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-11634
		FILM NUMBER:		251358271

	BUSINESS ADDRESS:	
		STREET 1:		1911 WALKER AVE
		CITY:			MONROVIA
		STATE:			CA
		ZIP:			91016
		BUSINESS PHONE:		6263037902

	MAIL ADDRESS:	
		STREET 1:		1911 WALKER AVE
		CITY:			MONROVIA
		STATE:			CA
		ZIP:			91016

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	STAAR SURGICAL COMPANY
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>d11821ddefa14a.htm
<DESCRIPTION>DEFA14A
<TEXT>
<HTML><HEAD>
<TITLE>DEFA14A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
<DIV STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;
</DIV><DIV STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</DIV> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 14A </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PROXY
STATEMENT PURSUANT TO SECTION 14(a) OF THE </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES EXCHANGE ACT OF 1934 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by the Registrant&#8194;&#9746; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by a party other
than the Registrant&#8194;&#9744; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Preliminary Proxy Statement </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Confidential, for Use of the Commission Only (as permitted by Rule</B><B></B><B><FONT
STYLE="white-space:nowrap">&nbsp;14a-6(e)(2))</FONT> </B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Definitive Proxy Statement </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9746;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Definitive Additional Materials </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Soliciting Material under &#167; <FONT STYLE="white-space:nowrap">240.14a-12</FONT> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>STAAR SURGICAL COMPANY </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Registrant as Specified In Its Charter) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Person(s) Filing Proxy Statement, if other than the Registrant) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment of Filing Fee (Check the appropriate box): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9746;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No fee required. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Fee paid previously with preliminary materials. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and <FONT
STYLE="white-space:nowrap">0-11.</FONT> </P></TD></TR></TABLE>
<P STYLE="font-size:30pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;
</DIV><DIV STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>On September&nbsp;30, 2025, Alcon and STAAR Surgical Company issued the following press release: </I></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g11821g36f93.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Alcon and STAAR Surgical Announce Expiration of Hart-Scott-Rodino Waiting Period for Alcon&#8217;s Acquisition of STAAR
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>GENEVA and LAKE FOREST, CA, September</B><B></B><B>&nbsp;30, 2025 &#8211; </B>Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to
helping people see brilliantly, and STAAR Surgical Company (NASDAQ: STAA) (&#8220;STAAR&#8221;), the manufacturer of the Implantable Collamer<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Lens (ICL), today announced that the waiting
period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (HSR), in connection with Alcon&#8217;s acquisition of STAAR, expired at 11:59 p.m. ET on September&nbsp;29, 2025. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As previously announced, under the terms of the agreement, Alcon will purchase all outstanding shares of STAAR common stock for $28 per share in cash, which
represents approximately a 59% premium to STAAR&#8217;s <FONT STYLE="white-space:nowrap">90-day</FONT> volume weighted average price and a 51% premium to the closing price of STAAR common stock on August&nbsp;4, 2025 (the day prior to the
transaction announcement). The transaction represents a total equity value of approximately $1.5&nbsp;billion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#8220;We are pleased to reach this
milestone towards the closing of our acquisition of STAAR. Together with STAAR, Alcon will be able to offer treatment options across the full spectrum of myopia, reinforcing our commitment to addressing the most significant needs in eye care,&#8221;
said David Endicott, CEO of Alcon. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#8220;With the expiration of HSR, we are one step closer toward completing this value-maximizing transaction for
STAAR stockholders. In addition to providing our stockholders with compelling, certain, and premium cash value, Alcon&#8217;s resources will enable us to accelerate adoption of EVO ICL by surgeons and patients. We look forward to closing the
transaction and delivering to our stakeholders its many benefits,&#8221; said Stephen Farrell, CEO of STAAR. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Alcon and STAAR continue to anticipate that
the transaction will close within six to 12 months of the initial merger agreement announcement, which occurred on August&nbsp;5, 2025, subject to customary closing conditions, including regulatory approval and approval by STAAR&#8217;s
stockholders. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>STAAR will hold a virtual Special Meeting of Stockholders on October&nbsp;23 at 8:30 a.m. (Pacific Time) to vote to adopt the Alcon
merger proposal. Stockholders of record as of the close of business on September&nbsp;12, 2025, are entitled to vote at the meeting. The STAAR Board of Directors unanimously recommends that all STAAR stockholders vote &#8220;FOR&#8221; the merger
proposal on the &#8220;WHITE&#8221; proxy card TODAY. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">STAAR stockholders with questions about voting their shares should contact STAAR&#8217;s proxy solicitor,
Innisfree M&amp;A Incorporated: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">For stockholders: +1 <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">877-750-8233</FONT></FONT>
(toll-free) </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">For banks and brokerage firms: +1
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">212-750-5833</FONT></FONT> </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Morgan Stanley&nbsp;&amp; Co. LLC is
serving as financial advisor to Alcon, and Gibson, Dunn&nbsp;&amp; Crutcher LLP is serving as legal advisor to Alcon. Citi is serving as the exclusive financial advisor to STAAR, and Wachtell, Lipton, Rosen&nbsp;&amp; Katz is serving as legal
advisor to STAAR. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>About Alcon </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Alcon helps
people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people&#8217;s lives. Our Surgical and Vision Care products touch the lives of
more than 260&nbsp;million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 25,000 associates are enhancing the quality of life through innovative products,
partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at www.alcon.com. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>About STAAR Surgical
</U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">STAAR Surgical (NASDAQ: STAA) is the global leader in implantable phakic intraocular lenses, a vision correction solution that reduces or
eliminates the need for glasses or contact lenses. Since 1982, STAAR has been dedicated solely to ophthalmic surgery, and for 30 years, STAAR has been designing, developing, manufacturing, and marketing advanced Implantable Collamer<SUP
STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Lenses (ICLs), using its proprietary biocompatible Collamer material. STAAR ICL&#8217;s are clinically-proven to deliver safe long-term vision correction without removing corneal tissue or the
eye&#8217;s natural crystalline lens. Its EVO ICL<SUP STYLE="font-size:75%; vertical-align:top">&#153;</SUP> product line provides visual freedom through a quick, minimally invasive procedure. STAAR has sold more than 3&nbsp;million ICLs in over 75
countries. Headquartered in Lake Forest, California, the company operates research, development, manufacturing, and packaging facilities in California and Switzerland. For more information about ICL, visit www.EVOICL.com. To learn more about STAAR,
visit www.staar.com. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Additional Information About the Merger and Where to Find it </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This communication relates to the proposed transaction involving STAAR. In connection with the proposed transaction, STAAR has filed relevant materials with
the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;), including STAAR&#8217;s definitive proxy statement on Schedule 14A (the &#8220;Proxy Statement&#8221;), on September&nbsp;16, 2025. The Proxy Statement was first sent to STAAR
stockholders on September&nbsp;16, 2025. This communication is not a substitute for the Proxy Statement or any other document that STAAR may file with the SEC or send to its stockholders in connection with the proposed transaction. BEFORE MAKING ANY
VOTING DECISION, STOCKHOLDERS OF STAAR ARE URGED TO READ ALL RELEVANT DOCUMENTS FILED OR TO BE FILED WITH THE SEC, INCLUDING THE PROXY STATEMENT, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS THERETO, IN CONNECTION WITH THE PROPOSED TRANSACTION WHEN THEY
BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION. Investors and security holders will be able to obtain the documents (when available) free of charge at the SEC&#8217;s website, www.sec.gov, or by
visiting STAAR&#8217;s investor relations website, https://investors.staar.com. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>No Offer or Solicitation </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This communication is for informational purposes only and is not intended to and does not constitute, or form part of, an offer, invitation or the solicitation
of an offer or invitation to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of any securities, or the solicitation of any vote or approval in any jurisdiction, pursuant to the proposed transaction or otherwise, nor shall there
be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Participants in the Solicitation
</U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under SEC rules, Alcon, STAAR and certain of their respective directors, executive officers and other members of management and employees may be
deemed to be participants in the solicitation of proxies from the holders of STAAR&#8217;s common stock in connection with the proposed transaction. Information regarding Alcon&#8217;s directors and executive officers is contained in Alcon&#8217;s
annual report on Form <FONT STYLE="white-space:nowrap">20-F</FONT> for its fiscal year ended December&nbsp;31, 2024, which was filed with the SEC on February&nbsp;25, 2025. Information about the directors and executive officers of STAAR and their
ownership of STAAR&#8217;s common stock is set forth in the Proxy Statement, the definitive proxy statement for STAAR&#8217;s 2025 Annual Meeting of Stockholders, which was filed with the SEC on April&nbsp;24, 2025 (and which is available at
https://www.sec.gov/ix?doc=/Archives/edgar/data/0000718937/000095017025058174/staa-20250424.htm), including the sections captioned &#8220;Compensation of Directors,&#8221; &#8220;Information Regarding Executive Officers&#8221; and &#8220;Security
Ownership of Principal Shareholders and Management,&#8221; or its Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;27, 2024, which was filed with the SEC on February&nbsp;21, 2025 (and which is
available at https://www.sec.gov/ix?doc=/Archives/edgar/data/0000718937/000095017025024813/staa-20241227.htm), and in other documents filed by STAAR with the SEC. To the extent holdings of such participants in STAAR&#8217;s securities have changed
since the amounts described in the Proxy Statement, such changes have been reflected on Initial Statements of Beneficial Ownership on Form 3 or Statements of Change in Ownership on Form 4 filed with the SEC by STAAR&#8217;s directors and executive
officers. These documents can be obtained free of charge from the sources indicated above. Additional information regarding the participants in the proxy solicitation and a description of their direct and indirect interests, by security holdings or
otherwise, will be contained in other relevant materials to be filed with the SEC in respect of the proposed transaction when they become available. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Forward-looking Statements </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information
covered by this communication contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements often contain words such as &#8220;anticipate,&#8221; &#8220;believe,&#8221;
&#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;estimate,&#8221; &#8220;project,&#8221; &#8220;continue,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;may,&#8221; and similar terms. All statements in this communication that are not
statements of historical fact are forward-looking statements. These forward-looking statements are neither promises nor guarantees and involve known and unknown risks, uncertainties and other important factors that may cause actual results,
performance or achievements to be materially different from what is expressed or implied by the forward-looking statements, including, but not limited to: (1)&nbsp;the occurrence of any event, change or other circumstances that could give rise to
the termination of the Alcon merger agreement or could cause the consummation of the proposed transaction to be delayed or to fail to occur; (2)&nbsp;the failure to obtain approval of the proposed transaction from STAAR&#8217;s stockholders;
(3)&nbsp;the failure to obtain certain required regulatory approvals or the failure to satisfy any of the other closing conditions to the completion of the proposed transaction within the expected timeframes or at all; (4)&nbsp;risks related to
disruption of management&#8217;s attention from ongoing business operations due to the proposed transaction; (5)&nbsp;the effect of the announcement of the proposed </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
transaction on the ability of STAAR to retain and hire key personnel and maintain relationships with its customers, suppliers and others with whom it does business, or on its operating results
and business generally; (6)&nbsp;the ability of STAAR to meet expectations regarding the timing and completion of the transaction; (7)&nbsp;the outcome of any legal proceedings that may be instituted against STAAR related to the proposed
transaction; (8)&nbsp;the possibility that STAAR&#8217;s stock price may decline significantly if the proposed transaction is not consummated; and (9)&nbsp;other important factors set forth under the caption &#8220;Risk Factors&#8221; in each of the
Proxy Statement, Alcon&#8217;s Annual Report on Form <FONT STYLE="white-space:nowrap">20-F</FONT> for the fiscal year ended December&nbsp;31, 2024, and STAAR&#8217;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year
ended December&nbsp;27, 2024, as any such factors may be updated from time to time in STAAR&#8217;s and Alcon&#8217;s other filings with the SEC, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Forward-looking statements speak only as of the date they are made and, except as may be required under applicable law, Alcon and STAAR undertake no
obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Alcon Investor
Relations </U></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Daniel Cravens, Allen Trang </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">+ 41 589 112
110 (Geneva) </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">+ 1 817 615 2789 (Fort Worth) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">investor.relations@alcon.com </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Alcon Media Relations
</U></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Steven Smith </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">+ 41 589 112 111 (Geneva) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">+ 1 817 551 8057 (Fort Worth) </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">globalmedia.relations@alcon.com
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>STAAR Investor Relations </U></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Niko Liu, CFA </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">United States: +1 <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">626-303-7902</FONT></FONT> (ext 3023) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Hong Kong: <FONT STYLE="white-space:nowrap">+852-6092-5076</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">nliu@staar.com </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">investorrelations@staar.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>STAAR Media Relations </U></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Connie Johnson </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">+1 <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">626-303-7902</FONT></FONT> (ext 2207) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">cjohnson@staar.com </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Lucas Pers / Alexandra Benedict </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Joele Frank, Wilkinson Brimmer Katcher </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">+1 <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">212-895-8692</FONT></FONT> / +1 <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">212-895-8644</FONT></FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g11821g36f93.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g11821g36f93.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" $6 S,# 2(  A$! Q$!_\0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MGA?;U(V=VG\K'EYC@OJU7D3N@HHHKZ<\\**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@#^ORBBBOY//U0_D#HHHK^L#\K"BBB@!)+.2_ AAC>6:5E1(T&
M6D8D */<G%?TJ?L&_ /3O^"='_!._1++7BME-H>C2^(_$UR>#]J>/SY\L>Z
M",?[@K^:^UNY]/NHKBUGEM;FWD6:&:)MKQ.IRK*>Q!Z&NW\3_M3?%'QMX;N=
M)UCXD^.]5TV]B,-S:W>NW,T%S&3RCHSE6![Y%?&<5Y#B,T5.G3FE"+N[]?0]
M7+<=2PW-S*[>Q^G;_P#!U1#.C*GP/N#&2=C'Q*JDKG@D>1QGZ_C7WW^QI^TY
MX?\ ^"FG['\?BC^Q_L6G>)([O1M8T:299_LK#=%+"7  ;*%6!P.''%?S',NZ
M/&<],D]ZZ_P%\?O'GPHTN2R\*^./%OABRGD,TMOI6JS6L4LF,;V5& +8 &?8
M5XV9^'=!TH_4O<FK.[NSKH9]54_W^L6?K1_P0-_9UU/]DO\ ;O\ VEOAYJ:2
M>;X8CL;>W=E.+BV:>=X)5]FB*GZY]*7]NS]KNS_8C_X+X>!_%^O!H_#.H^"K
M?1-7F7DVT%Q-,!-CN$D1&/\ LJU?D_8?M-?$S2O$5[K5O\1O'$6M:G''!>:@
MFM7"W-U%'GRTDD#;G5<G:#P,FL#QO\1?$?Q.UU-3\3^(-:\2ZBD2P+=:I>R7
M<ZQC)";W).T$DXSW-.'!.(JXF5?$S34HV>CWLD)YO"%%4Z4;-.Y_01_P4&_X
M)+_#S_@J5<^&_'$?BV^T;4[>R$-MK.C"*]MM2L68R*A4G#8+,593_&0<BOAW
M]O#_ ()Y^&_^".'Q4^"/QK^'NKRW^G^&]8M8M8T?5;U#J.HR)G?<PKP65T+A
MT480[".":^!_@[^V'\6_V>],FL? WQ+\8^%+"9MQL[#4'6W4GJ1&V4&?8"N8
M^)/Q9\5?&?Q5_;7C'Q)KOBK6'&S[7JEX]S(H]%+'Y1[# K++^#LTIU/83Q'[
MFS5NZ[#Q&9X>JN>,/?[G]#/[4W[*?PJ_X+4?LL^'KW3O$TYL/,_M/0]>TLI+
M-82.@66&6)N.1A7C;!!4=,4W]EG]DCX6_P#!%C]E[Q)J%WXGN6L9I1J?B#7M
M7:.*2\:--L<44:\#C(2-<L2W4YK^?OX,_M$_$']G._N+CP%XX\3^$9KK_6_V
M7?O#'*?5HP=A/N033OC%^T?\1/VAKZ&?Q[XY\3^+WMSF#^U;]YDA/JJ?=4^X
M&:Y?]0\?_NOM_P!Q>]C59W2LYN'O]S]??^" 7QMG_:4_:B_:F^(5Q;-:?\)?
MK%AJ$<!Y:")O/6-#CN$50?<&OE?_ (++6CR?\%T]!8#Y/M7ACC.,?.E?#'PR
M^,?C+X,M>GPIXN\2^'/[1V_:AI>HRVGG[<[=QC8;L9/7UJKXJ^(OB3QOXTC\
M1:QXDUS5M>B,934+V\>:Z7RS^[Q*Q+_+@8YXQ7K8?@RI1S"=>$UR./*EUVL<
MKS52P\:4E[R=S^@C_@X2B+_\$N/'!"_=O]*/3I_I\-?SOUV_CW]I;XD?$_1)
MM+\0_$'QKKFDW#(TMC?ZU<7-M*R-N4LCN5)# $<=A7$5[?"F15LKPKHUFFW)
MO3T1SYGC8XFISP5@HHHKZD\P**** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@#^ORBBBOY//U0_D#HHHK^L#\K"BBB@ HHHH **** #-%%% !1FBB@ I<YI
M** #/%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!
M_7Y1117\GGZH?R!T445_6!^5A1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?U^4445_)
MY^J'\@=%%%?U@?E84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ']?E%%%?R>?JA_('11
M17]8'Y6%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110!_7Y1117\GGZH?R!T445_6!^5A1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 ?U^4445_)Y^J'\@=%%%?U@?E84444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% ']?E%%%?R>?JA_('1117]8'Y6%%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 444N.* $HHHH **7&:,4
M )1110/?8*.M%'>@-MPHH'+8[T%MH;('R=>>M-Z$\R"BFM.J[>VZA)1*S!?F
MV_W>?Y5.Y#JPC\3MZCJ6K=EX=U+4MOV?3-2N-W3R[5V_D*V;'X,^,-3_ -1X
M5U^0>OV-U_GBJLSGGF&&@KRFOO.;-)FN^L_V7?B)?(I3PGJ:!NGFM''_ #:M
M:S_8Q^(=SP^D6UO@\B6]C']:?)+L<4^(<OAI*K'[T>5T5[/:?L)^-YX_WCZ%
M#_O79/\ )36A:_\ !/\ \3SDB36M!AP,Y!E?_P!E%4J4^J..7%^4Q^*LCPC-
M%?0=O_P3VU9XAYWB;3!SSMM9#C]:OP_\$]&:;,OBR/'^Q8'^K4_92.=\;Y.M
MZI\VYHKZ;C_X)WV7\?BR[(_V;%<_^A587_@GGI!ERWBG5,8QQ:1@_P#H5/V$
MCGEQ]DZ7\0^7**^JD_X)Z>'0O/B37<_]<8J7_AWWX>CZ>(-<;W,47^%/V$^Q
MG_Q$/)U]O\#Y5S1FOJU?^"?/AK(W>(-=8=QY<0_I2O\ \$^?#1<[?$&NH,\#
MRXCC]*/J\P_XB)DW\Y\HTE?5B?\ !/GPXR-CQ#KHYY_=14UO^">GAW.1XDUX
M?]L8J7L)]AKQ"R=_;_ ^5=U%?4:?\$\M(4.!XIU7!.<&SC_^*J"7_@GA9&4&
M/Q;=J!ZV"G_V>CV,WT-H\>Y._P#EY^#/F.EQ7TC+_P $\G^?RO%T>.WF6!_H
MU9\W_!/;5XP?)\3Z4Q[!K609_4T>QDB_]><H;M[5'S[THKW:Y_8"\4QM^[UK
M09>.<M(O_LIK.N_V%_'$978VASC=U6[*G]5%1[*1UT^+,JE_R]7WGC6:*]2N
M?V,_B#;+_P @>TF]X[V,_P!167>_LO?$*R49\*ZC( /^611\?DU+DEV.N'$.
M72VJQ^]' TN*Z34?@WXOTLG[1X6UZ/\ [<W;^0-8EYH.H:<V+C3M1@/_ $TM
MG7^8J3MAF.%G\-1?>5:*8\XC^]E?7<,4JS*XR.<^E!T1JPEHF.HI-V:<!E<T
MKEIIZ(2BEQ24RK!12T=:!"44N,4E !11UHH **7&:2@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#^ORBBBOY//U0
M_D#HHHK^L#\K"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4MD1Q1X'%/ Q2]**!A1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M,T4CJ\S^ORBBBOY//U,_D.T'P[J7BR_6UTFPN]1NF.T16\1=L^^.E>U_#O\
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M*SM91;UZN]D:U*N(;E25VY27W)79])?L/_&Z;XV?L]:/J-_.USJUJ'L-1D?
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M%U:L XBE&[ )!Z@C/':O#/V>/V0OB+\6_@AJ>N1^.7\/VGCR6>?4=,GT_?\
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M9")5W)@<9([$UIR?$/P!X]_9/^+5K\//!>K>&U33@]U%+IQM_M3L,*RC+%B
M#^=/V5Z%*:CH]]%;<Q<^6M4AS;;7;OMT,/XG?'CQQI?_  3@\&>*+;Q1JD'B
M*_O%2YU%67SYES,,$[<?PKV[5]G>&+R6X\#64\CLT\EC&[N>KN8P23^-?!GQ
M8TZZ?_@EAX!MEM+LS_V@NZ+R'+K\\_)7&?TKW[X(_MX>&_B5K&A^#K31/%UO
M?7ENMH)[K3/+MU9(^26W<#Y3VK#&87FASTUHI._I<Z,%BW3JN-63NXQLO,B_
MX)P?$3Q#\4_AUXIO/$FLWFM3VOB*:UADNB&,,.Q#Y8P!\N2:X7]GWXW>+O$/
MA+]H"74/$6IWDGAZ2X72GD<9TX 3[1'QVV+C.>E<Y\"/C9??L&:MXP\)^*_"
MOB:[CO=6>_TZ[T^S\Z*[!&T8;@$$*IR,XY!Q6M^S%\,O$&C_ +.'QJ\4:SIE
MUI7_  F<%W>65E+$WG+'LE8,5QGDR8 QSMSWK>IA80E.K)>ZW'E^\PIXNK.$
M*,&^>*E?[M"#]@#]JGQ3<>-;/PQ\0-8O-43Q?:B^T*^O".64LKQ!@!D':<?[
M2^]=;^SW^T;JVE'XZZWXEU?4-8TSP7J4HLH)9 1#&IDVQ)@<9(4<YK@-&^ N
MH?$#_@GCX%\0:1#<6_C+P1YVH6)V%)V59W=X\8SG@,!ZCWIG[&GA+4?CS\*O
MCE8S03V%_P",'65!-$T2K.R._!8#CS/R!KJQ%'"U?:5HI))I/[]U_P!NF&&K
M8JE*%)WV;7W:)_,V_AE_PN;]I3P9;^-K[XJV'PZTK5)I/[,LHHHU5D5B!]XC
M(XQR23@GBOK+X(6^J:;\,](M=:UZU\3ZM#$5O-3M]OEW4FXY(V\<<#\*_/\
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C5>O>BBIBWH:.*6J'T4458!1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
